SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,261,000 | -17.1% | 129,607 | -31.4% | 0.80% | -3.4% |
| Q3 2020 | $3,936,000 | -23.5% | 188,878 | -12.9% | 0.82% | -19.7% |
| Q2 2020 | $5,148,000 | -26.2% | 216,743 | -44.1% | 1.03% | -5.2% |
| Q1 2020 | $6,980,000 | -28.2% | 387,985 | -5.3% | 1.08% | +16.6% |
| Q4 2019 | $9,723,000 | -16.4% | 409,908 | -3.1% | 0.93% | +5.7% |
| Q3 2019 | $11,630,000 | +197.4% | 423,230 | +258.2% | 0.88% | +213.9% |
| Q2 2019 | $3,910,000 | – | 118,148 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |